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ABSTRACT  
Three-Dimensional (3D) printing is a process where objects are made in successive layers under computer control by fusing or depositing 
materials. The objects can be of nearly any shape or geometry and come in a computer-aided (CAD) design from a 3D model. Since 3D printing 
began in 1984, it has changed enormously and has been used in a wide range of fields, including medicine and architecture. 3D printing moves 
rapidly and in future will transform and change the way we live and work from laboratory-based organs to pharmaceutical supplies. 3D 
printing in pharmaceuticals has been used to produce many novel dosage forms like microcapsules, complex drug-release profiles, 
nanosuspensions, and multilayered drug delivery devices. It also offers important advantages from the industrial point of view such as cost-
efficiency, higher productivity, democracy-making and enhanced cooperation. Keeping in view the recent approval given by USFDA to many 
drug the focus has now shifted to the personalized medicine as it offers an important benefit to patients who need medications that have 
narrow therapeutic index or a higher predilection to be influenced by genetic polymorphisms. 3D printer is now seen as a valuable, efficient and 
economical tool to manufacture individualized medications, tailored to specific patients based on their needs and thereby change the future of 
pharmacy practice in general and pharmaceutical care in particular. 
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INTRODUCTION 
Three-dimensional printing (3DP) technology relies on 
computer- aided designs to achieve unparalleled flexibility, 
time-saving, and exceptional manufacturing capability of 
pharmaceutical drug products. The process involves 3D 
proto-typing of layer-by-layer fabrication (via computer-
aided design models) to formulate drug materials into the 
desired dosage form [35]. It is a method of manufacturing 
objects by fusing or depositing materials (such as plastics, 
metals, ceramics, powders, liquids, or even living cells) into 
layers to produce a 3D object. Additive processes are used in 
3D printing, in which successive layers of material are placed 
under computer control, thus also called as additive 
manufacturing (AM) .These objects can be of almost any 
shape or geometry, and are produced from a 3D model as 
defined in a computer-aided design (CAD)[1,6].The 3D 
printing process was first described in the 1980s and since 
then 3D printing has been used in a wide range of fields, 
including architecture, medicine and food industry and 
recently in pharmaceutical manufacturing [6, 9]. 
As the pharmaceutical industry shifts from mass production 
to personalized medicine, 3D printing will become part of the 
drug production line, promising future production of drugs 
printed on demand, at custom dose levels, with increased 
productivity and cost-effectiveness[4,5].The USFDA approved 
3D printed drug Levetiracetam (SPRITAM®) for the first 
time in 2015[4].  
BACKGROUND  
In 1884, when Charles Hull invented a stereo lithograph, 3D 
printing technology became apparent first[4,8,9]. He was then 
the co-founder of three-dimensional systems. The big 
development of the 3D system took place in 1992, when this 
year two 3D presses were developed, the 3D printer SLA 
(stereo lithographic device) and the SLS (selective laser 
sinters) 3D printer. The wax printer of Model Mark was 
launched in 1994. Aeromet invented 3D laser printing in 
1997. 3D printing in 1999 led to new developments in 
medicine, as the first lab organ grown in humans is 
implanted.The first inject printer was developed by Object 
Geometries in 2000 and the first multicolor 3D press was 
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made by Z Corporation. Solid imension produced the first 3D 
desktop printer in 2001. The first 3D printed functional 
kidney designed to filter blood and produce diluted urine in 
the animals was found to be revolutionizing in medicine in 
2002. In 2006, the first SLS (Select Laser Sintering) press 
was developed to achieve a breakthrough in the mass 
customization and on-demand production of industrial 
components and prostheses. The SLC resulted in a 3D-
printed prosthetic leg being taken by the first person in 
2008.  
The launch of the reprap project in 2005 marked the biggest 
advance of 3D printing technology, and in 2008 this project 
released Darwin, the first self-reproduction printer to print 
most of its own components. Organovo produced its first 3D 
bioprinted blood vessel in 2009. For the first time, 3D 
printing technology helps to develop robotics, 3D printed 
cars and even 3D printed silver and gold jewelry in 2011.The 
world's first 3d printed weapons was developed in 2013 and 
successfully shot [8,9]. The world's first 3D printed drug 
(Spitram) produced by Aprecia Pharmaceuticals was 
approved by the USFDA in 2015. In this context, the first 3D 
printed drug was developed. Spitram is produced by Aprecia 
using 3D printing platform with the ZipDose technology 
which creates high dose orodispersible formulations for the 
mouth with the liquid [1,4]. 
WORKING OF 3D PRINTER 
It all starts with making a virtual design of the object you 
want to create. This virtual design is made in a CAD 
(Computer Aided Design) file using a 3D modeling program 
or with the use of a 3D scanner (to copy an existing object). A 
3D scanner makes a 3D digital copy of an object [9] to prepare 
a digital file for printing, the 3D modeling software “slices” 
the final model into hundreds or thousands of horizontal 
layers. When the sliced file is uploaded in a 3D printer, the 
object can be created layer by layer. The 3D printer reads 
every slice (as 2D image) and creates the object, fussing each 
layer with hardly any visible sign of the layers with the result 
three dimensional objects are formed [1,9]. 
3D PRINTING   INDUSTRY 
At present, the impact of 3D printing in medicine remains 
small. 3D printing is currently a $700 million industry, with 
only $11 million (1.6%) invested in medical applications. In 
the next 10 years, however, 3D printing is expected to grow 
into an $8.9 billion industry, with $1.9 billion (21%) 
projected to be spent on medical applications [6]. 
 
 
TYPES OF 3D PRINTING TECHNOLOGIES 
Table 1: Examples of current 3DP technologies in pharmaceutical drug delivery 
Type of 3DP 
Technology 
Details Ref 
Inkjet Printing In the technique, different combinations of active ingredients and excipients (ink) are 
precisely sprayed in small droplets (via drug on demand) or continuous jet method) in 
varying sizes layer by layer into a non-powder substrate. The technique encompasses 
powder-based 3D printing that uses a powder foundation (powder substrate) for the 
sprayed ink where it solidifies into a solid dosage form. 
[26,27, 
28, 29, 
30] 
Direct-write Uses a computer-controlled translational stage that moves a pattern-generating device 
in order to achieve, layer-by-layer,3Dmicrostructure. 
[31] 
Zip Dose Provides a personalized dose in addition to the delivery of a high drug-load with high 
disintegration and dissolution levels by manufacturing highly porous material. 
[32] 
Thermal Inkjet 
(TIJ) printing 
TIJ system consists of a micro-resistor that heats a thin film of ink fluid (located in the 
ink reservoir) forming a vapor bubble that nucleates and expands to push the ink drop 
out of a nozzle. TIJ affords the opportunity of dispensing extemporaneous 
preparation/solution of drug onto 3D scaffolds (drug carriers/films). 
[22,25] 
Fused deposition 
modelling (FDM) 
The process can be applied to multiple dosage forms that apply polymers as part of the 
framework such as implants, zero-order release tablets, multi-layered tablets and fast-
dissolving devices. In the process the polymer of interest is melted and extruded 
through a movable heated nozzle. The layer by layer ejection of the polymer is 
repeated along x-y-z stage, followed by solidification to create a shape previously 
defined by the computer aided design models. 
[27,29, 
16, 33] 
 
APPLICATIONS OF 3D PRINTING 
Manufacturing industries have been using 3D printers for 
more than decades, but mostly to make prototypes rapidly 
and cheaply. The majority are used as functional models, 
prototypes, and casting patterns, or for presentation models. 
As the technology is getting better and better more things 
are being printed as finished goods, around 28% of the 
output of 3D printers is now final products rather than 
prototypes, and this is expected to rise to 50% by 2016 and 
80% by 2020. 
Various applications of 3D printing but the focus of these 
applications is mainly on finished products [7]. 
A. Hearing aids: 3D printing technology for manufacturing 
hearing aids was introduced a decade ago and it has 
shortened the manufacturing process to three steps: 
scanning, modelling, and printing. Printers can print 65 
hearing aid shells or 47 hearing aid moulds within 60 to 
90 minutes. The printing speed helps manufacturers to 
adjust demand to supply [7]. 
B. Automobile components: 3D printing technology is 
used by BMW manufacturers to produce prototypes of 
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metallic parts. This technology is used to produce engine 
parts of motor sports racing cars by utilising direct metal 
laser sintering process. Some luxury car manufacturers 
as Bentley and Rolls-Royce are using 3D printing 
technology to produce some parts more economically 
then conventional method of manufacturing. Tesla, the 
producer of electric cars, also produces automobile 
components by using 3D printers [7]. 
C. Aircraft components: European Aeronautic Defence and 
Space Company has developed the aircraft machined 
parts by 3D printing technology which are up to 65% 
lighter and equally strong compared to those 
manufactured by traditional methods.Airbus produced a 
door bracket for the A350-1000 in 2011 by using 3D 
printing technology. It takes the 200-Watt laser two 
hours to complete the print job of these components. The 
Boeing Company has been utilizing SLS (Selective Laser 
Sintering) for flight hardware in regular production since 
2002, for both military and commercial programs. [7] 
D. Weapons: The world’s first handgun made almost 
entirely by a 3D printer was printed and tested in 2013. 
15 out of 16 pieces were printed by a 3D printer using 
ABS plastic as a material [7]. 
E. Sports: For the first time Nike produced a part, the plate, 
of a sports shoe by using AM technique (Selective Laser 
Sintering technology) [7]. 
F. Other applications: A huge range of products are 
manufactured by 3D printing includes jewelry, games, 
fashion (E.g. belts, wallets), lamps, furniture, articles for 
dining and other accessories, gadgets and design articles. 
Other applications exist also in the food sector. The 
University of Exeter developed a 3D printer for chocolate. 
The chocolate printer prints out chocolate layer by layer to 
create a 3D shape, without any molding tools. This gives the 
opportunity that own designs and chocolate articles can be 
created and printed out at local chocolate outlets [7]. 
Apart from the production of goods also the manufacturing 
of 3D printing machines has become a business, in 2008 first 
self-replicating printer was released that is able to print the 
majority of its own components [7, 9]. 
G. Medical applications: 3D printing has been applied in 
medicine since the early 2000s, when the technology was 
first used to make dental implants and custom 
prosthetics. Since then, the medical applications for 3D 
printing have evolved considerably. Recently published 
reviews describe the use of 3D printing to produce bones, 
ears, exoskeletons, windpipes, a jaw bone, eyeglasses, cell 
cultures, stem cells, blood vessels, vascular networks, 
tissues, and organs, as well as novel dosage forms and 
drug delivery devices [6]. 
H. Dentistry: 3D printing is widely used in dental labs, if 
takes the efficiencies of digital design to the production 
stage. By combining oral scanning, CAD/CAM design, and 
3D printing, dental labs can accurately and rapidly 
produce Crowns, Bridges, Stone models and range of 
orthodontic appliances [7]. 
I. Tissue: For the first time in 2012 the lower jaw of a 
patient was completely replaced by an artificial jaw 
which was 3D printed. Titanium powder was used for 
printing the implant. 1 mm of the implant exists of 33 
printed layers. The titanium body is coated with bio-
ceramics. Parts of bones and more often parts from faces 
or ears are produced by 3D printers. Scientists developed 
an artificial ear with the help of 3D printing. This is 
purposely different from the natural human ear. An 
antenna which is part of the artificial ear registers 
frequencies a human cannot hear. Future applications in 
this sector are 3D printed organs. However, research in 
this area is still far away from practical applications 
which would mean transplantation [7]. 
J. Pharmaceutical Applications of 3D Printing 
Pharmaceutical applications for 3D printing are expanding 
rapidly and are expected to revolutionize health care. 3D 
printing technologies are already being used in 
pharmaceutical research and fabrication. Advantages of 3D 
printing include precise control of droplet size and dose, high 
reproducibility, and the ability to produce dosage forms with 
complex drug-release profiles. 3D printing technology makes 
complex drug manufacturing processes more standardized, 
simpler and more viable. 3D printing technology is also 
valuable tool in the development of personalized medicine. 
3D printing technology allows drug dosage forms, release 
profiles, and dispensing to be customized for each patient [6] 
.3D printing can lead to drugs actually manufactured by 
“precision drug dispensing”. The drugs themselves could be 
tailored to meet various precise specifications and address 
the unique needs of individuals taking them [4,6]. Application 
of 3D printing technology in pharmaceutical manufacturing 
could have following potential benefits [6]. 
Personalized Medicine: The purpose of drug development 
should be to increase efficacy and decrease the risk of 
adverse reactions, a goal that can potentially be achieved 
through the application of 3D printing to produce 
personalized medications. Oral tablets are the most popular 
drug dosage form because of ease of manufacture, pain 
avoidance, accurate dosing, and good patient compliance. 
However, no viable method is available that could routinely 
be used to make personalized solid dosage forms, such as 
tablets. Oral tablets are currently prepared via well-
established processes such as mixing, milling, and dry and 
wet granulation of powdered ingredients that are formed 
into tablets through compression or molds. Each of these 
manufacturing steps can introduce difficulties, such as drug 
degradation and form change, possibly leading to problems 
with formulation or batch failures. In addition, these 
traditional manufacturing processes are unsuitable for 
creating personalized medicines and restrict the ability to 
create customized dosage forms with highly complex 
geometries, novel drug-release profiles, and prolonged 
stability.  
Personalized 3D-printed drugs may particularly benefit 
patients who are known to have a pharmacogenetic 
polymorphism or who use medications with narrow 
therapeutic indices. Pharmacists could analyze a patient’s 
pharmacogenetic profile, as well as other characteristics 
such as age, race, or gender, to determine an optimal 
medication dose. A pharmacist could then print and dispense 
the personalized medication via an automated 3D printing 
system. If necessary, the dose could be adjusted further 
based on clinical response.  
3D printing also has the potential to produce personalized 
medicines in entirely new formulations, such as pills that 
include multiple active ingredients, either as a single blend 
or as complex multilayer or multi-reservoir printed tablets.  
Patients who have multiple chronic diseases could have their 
medications printed in one multidose form that is fabricated 
at the point of care. Providing patients with an accurate, 
personalized dose of multiple medications in a single tablet 
could potentially improve patient compliance [6]. 
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Complex Drug-Release Profiles 
The creation of medications with complex drug-release 
profiles is one of the most researched uses of 3D printing. 
Traditional compressed dosage forms are often made from a 
homogeneous mixture of active and inactive ingredients, and 
are thus frequently limited to a simple drug-release profile. 
However, 3D printers can print binder onto a matrix powder 
bed in layers typically 200 micrometers thick, creating a 
barrier between the active ingredients to facilitate controlled 
drug release. 3D-printed dosage forms can also be fabricated 
in complex geometries that are porous and loaded with 
multiple drugs throughout, surrounded by barrier layers that 
modulate release [6]. 
Oro-dispersible high-dose medications 
3D printing technology helps to produce Oro-dispersible 
high-dose medications (up to 1000 mg) without using 
compression forces or traditional molding techniques.  
3D printer stitches together multiple layers of powdered 
medication using an aqueous fluid to produce a porous, 
water-soluble matrix that rapidly disintegrates with a sip of 
liquid[1]. 
3D PRINTED PHARMACETICAL FORMULATIONS  
First 3D printed drug [Spitram (levetiracetam)] 
manufactured by Aprecia Pharmaceuticals was approved by 
USFDA [1,4,11]. Spitram is produced by using Aprecia’s ZipDose 
technology [3,4,11]. This Technology is Aprecia's unique 
delivery platform which is designed to enable delivery of 
high-dose medications in a rapidly disintegrating form [3,4,12]. 
 ZipDose Technology product candidates are assembled 
layer-by-layer without using compression forces or 
traditional molding techniques. Thin layers of powdered 
medication are repeatedly spread on top of one another, as 
patterns of liquid droplets (an aqueous fluid) are deposited 
or printed onto selected regions of each powder layer. 
Interactions between the powder and liquid bond these 
materials together at a microscopic level [4,12]. 
This platform yields highly porous structures even at high 
loading and doses of drug. The result is the creation of 
Aprecia’s unique ZipDose Technology product candidates 
that are designed to: 
 Rapidly disintegrate on contact with liquid by breaking 
the bonds created during the 3D printing process. 
 Support dose loading up to 1,000 mg. 
 Allows the application of enhanced taste-masking 
techniques [3,12]. 
Unique Dosage Forms: These dosage forms are produced 
using “inkjet-based 3D printing drug fabrication”, inkjet 
printers are used to spray formulations of medications and 
binders in small droplets at precise speeds, motions, and 
sizes onto a substrate. The most commonly used substrates 
include different types of cellulose, coated or uncoated 
paper, microporous bioceramics, glass scaffolds, metal alloys, 
and potato starch films, among others. Investigators have 
further improved this technology by spraying uniform “ink” 
droplets onto a liquid film that encapsulates it, forming 
microparticles and nanoparticles. Such matrices can be used 
to deliver small hydrophobic molecules and growth factors. 
In “powder-based 3D printing drug fabrication”, the inkjet 
printer head sprays the “ink” onto the powder foundation. 
When the ink contacts the powder, it hardens and creates a 
solid dosage form, layer by layer. The ink can include active 
ingredients as well as binders and other inactive ingredients. 
After the 3D-printed dosage form is dry, the solid object is 
removed from the surrounding loose powder substrate.  
This technology also offers the ability to create limitless 
dosage forms that are likely to challenge conventional drug 
fabrication. 3D printers have already been used to produce 
many novel dosage forms, such as: microcapsules, 
hyaluronan-based synthetic extracellular matrices, antibiotic 
printed micropatterns, mesoporous bioactive glass scaffolds, 
nanosuspensions, and multilayered drug delivery devices [6]. 
Drugs with complex geometries: 3D printing technology 
can be used to create medicinal tablets in various odd shapes 
that would be difficult to produce via traditional 
manufacturing methods. Researchers of the University 
College London (UCL) School of Pharmacy and FabRx, Ltd. In 
their study designed five tablets, each with a distinctly 
different shape — a cube, pyramid, cylinder, sphere, and 
torus (i.e. ring/donut) using auto CAD software. The sizes 
and shapes of each tablet were varied using the scale 
function of the software to fabricate tablets with a constant 
surface area (275 mm2), surface area/volume ratio (1:1), or 
weight (500 mg). In all cases, however, the ratio of the 
length, width, and height of each shape was kept constant. 
Finally, researchers printed each tablet using the drug-
infused filament and a “MakerBot Replicator 2X Desktop 3D 
printer”. Once the tablets were printed, researchers 
conducted dissolution tests to determine the drug release 
profile of each pill. They found that when the surface area of 
the printed tablets was kept constant, the drug release rates 
were the fastest in the pyramid-shaped tablet, followed by 
the torus, cube, sphere, and finally the cylinder. This order is 
directly correlated with the tablets’ surface area/volume 
ratio, with the pyramid tablet having the highest value and 
the cylinder the lowest. This led the researchers to conclude 
that the geometrical shape of a tablet undoubtedly influences 
its drug release profile. The visual appearance of a tablet is a 
very important consideration for patients. In particular, 
tablet size and shape are critical to patient medication 
adherence [2]. 
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TABLE 2: EXAMPLES OF PHARMACEUTICAL FORMULATIONS THAT WERE DEVELOPED BY 3D PRINTING TECHNOLOGY 
3DP Technology Dosage Forms Active Ingredients Ref 
Desktop 3D printer Tablet Guaifenesin [14] 
A laboratory- scale 3DP machine capsule Pseudoephedrine hydrochloride [15] 
Fused Deposition Modelling 
(FDM) 
Tablet 
5-aminosalicylic acid (5-ASA, mesalazine) and 
4-aminosalicylic acid (4-ASA) 
[16] 
3DP extrusion-based printing Tablet Captopril with Nifedipine and Glipizide [17] 
3DP technology Tablet Acetaminophen [18] 
Inkjet 3DP Implant Levofloxacin [19] 
3DP machine Multi-drug implant Rifampicin and Isoniazid [20] 
Inkjet 3DP Nanosuspension Folic Acid [21] 
Thermal Inkjet (TIJ) Printing Solution Salbutamol sulphate [22] 
Inkjet 3DP Nanoparticles Rifampicin [23] 
3D Extrusion Printing 
Encapsulated within 
apolymer(PLGA)poly(vinyl 
alcohol) (PVA) 
Dexamethasone- 21-phosphate disodium salt [24] 
Thermal Inkjet (TIJ) Printing Solid dosage forms Prednisolone [25] 
 
WHY 3D PRINTING? 
The application of 3D printing in Pharmaceuticals can 
provide many benefits, including: cost-effectiveness; 
increased productivity; the democratization of design and 
manufacturing; and enhanced collaboration [6]. 
Increased Cost Efficiency: The most important benefit 
offered by 3D printing is the ability to produce items 
cheaply. [4,6] Conventional method of drug manufacturing are 
less cost effective then 3D printing technology, because 
conventional method uses a lot of processes such as mixing, 
milling, dry or wet granulation, compression or molding etc. 
3D printing can also reduce manufacturing costs by 
decreasing the use of unnecessary resources. For example, a 
pharmaceutical tablet weighing 10 mg could potentially be 
custom-fabricated on demand as a 1 mg tablet. Some drugs 
may also be printed in dosage forms that are easier and 
more cost-effective to deliver to patients [6]. 
Enhanced Productivity: 3D printing technology is much 
faster than traditional method of drug manufacturing, which 
uses various processes such as mixing, milling, dry or wet 
granulation, compression or molding that makes it time 
consuming. In addition to speed, other qualities, such as the 
resolution, accuracy, reliability, and repeatability of 3D 
printing technologies, are also improving [6]. 
Environment friendly: 3D printing technology claims to 
have more environmental benefits than traditional drug 
manufacturing methods which needs huge setup to 
manufacture a pill[7]. 
Democratization and Collaboration: Another beneficial 
feature offered by 3D printing is the democratization of the 
design and manufacturing of goods [6]. 
BARRIERS AND CHALLENGES 
Post-processing: In many cases, 3D printer is unable to 
generate components with the desired accuracy and only 
produce products with nearly final shape. These products 
may then require a finishing operation, such as grinding or 
polishing, to produce the final product [7]. 
Limitations of Materials: The choice of different raw 
materials as feedstock for 3D printers is still rather limited. 
There might be physical and technical limitations regarding 
the diversity of potential raw materials [7]. 
Massive job loss: 3D printing technology will fall 
somewhere between the extremes of creating and 
destroying jobs. Currently, 3D printing serves as an 
indispensable tool for rapid prototyping, but as systems 
improve and become mainstream in manufacturing, 
3Dprinting technology will likely replace unskilled human 
labour needed for subtractive manufacturing processes. At 
the same time, skilled jobs in CAD design, math, materials 
engineering, and automation oversight will become more 
valuable [5]. 
Regulatory Concerns: Securing approval from regulators is 
another significant barrier that may impede the widespread 
pharmaceutical application of 3D printing. Only one dosage 
form printed by Aprecia pharmaceuticals has received the 
FDA’s approval till this date. However, fulfilling more 
demanding FDA regulatory requirements could be a hurdle 
that may impede the availability of 3D-printed drugs on a 
large scale [6]. 
FUTURE TRENDS  
3DP technology has many anticipated advantages that are 
not yet proven; as such continuous clinical development of 
3DP will require vision, money, and time [26,29]. We envisage 
that activities to develop 3DP from a broader appeal 
clinically will include (i) optimization and improvement of 
software performance, (ii) development of new excipients or 
assessment of old excipients for application in 3D 
formulations; and (iii) development and optimization of 
manufacturing process for a wide range of drug products, 
and (iv) clinical studies to assess efficacy, safety and stability 
of new 3D-based formulations. 
Apart from the cost of developing new formulations or re-
designing existing formulations through 3DP, the built-in 
flexibility may be a major source of liability from safety point 
of view. It is important to rule out tampering of the dose or 
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drug through the process to ensure there is no adulteration 
or mix-up of treatment regimens among patients. It is also 
anticipated that regulatory stipulations for 3DP formulations 
will be stringent in order to rule out illegal printing of drug 
products [26,29]. Thus, depending on the drug product, it is 
expected that a broad-based application of 3DP in 
pharmaceutical drug delivery will be greatly impacted by 
regulatory concerns and the need to have built- in tamper-
proof strategies. Although, 3DP is an adaptable technique for 
a broad range of pharmaceutical active ingredients, it is 
important to note that the impact of 3DP on physicochemical 
properties of a drug and excipients must be established on a 
case by case basis. This is because it is widely known that 
the therapeutic efficacy of any drug is affected by properties 
like drug-excipient interaction, polymorphic changes and 
stability in the dosage form. 
It can be anticipated that a faster way to broaden areas of 
application of 3DP in pharmaceutical drug delivery is to 
combine 3DP with conventional pharmaceutical 
technologies. Such hybrid systems will apply the proven 
effectiveness of conventional pharmaceutical technologies as 
well as exploit all the benefits of 3DP with respect to 
customization, precision and reduction of material wastage. 
CONCLUSION 
In conclusion,3D printing technology is expected to play an 
important role in the trend toward personalized medicine, 
through its use in customizing nutritional products, organs, 
and drugs.3D printing technology is expected to be 
especially common in pharmacy settings. The manufacturing 
and distribution of drugs by pharmaceutical companies 
could conceivably be replaced by emailing databases of 
medication formulations to pharmacies for on-demand drug 
printing. This would cause existing drug manufacturing and 
distribution methods to change drastically and become more 
cost-effective. If most common medications become 
available in this way, patients might be able to reduce their 
medication burden to one polypill per day, which would 
promote patient adherence [6]. 3D printing technologies are 
going to transform pharmacy practice by allowing 
medications to be truly individualized and tailored 
specifically to each patient, although technical and 
regulatory hurdles remain [4,6]. 
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